Literature DB >> 6982864

In vitro studies on the adjuvanticity of Brucella fractions.

A Serre, J P Vendrell, M F Huguet, A Cannat.   

Abstract

Two Brucella fractions, the murein-linked fraction PI and the murein-free fraction SF, behave as in vitro adjuvants for primary anti-sheep erythrocyte responses: added to Mishell and Dutton-type cultures of spleen cells from B6/DB F1 mice they significantly enhance the number of direct anti-sheep erythrocyte PFC observed on day 5. They exert both nonspecific, polyclonal activating effects and antigen-dependent specific adjuvanticity. These two functions, however, differ in their dose responses and in their cellular requirements and can therefore be dissociated. Thus, polyclonal activation requires high doses of the "adjuvant fraction," is enhanced by adherent-cell depletion, and is not impaired by T-cell depletion. Specific adjuvanticity, on the other hand, requires lower doses of the adjuvant fractions (very high doses are in fact suppressive) and is T-cell and adherent-cell dependent. Moreover, adjuvanticity can be transferred to unstimulated spleen cells (or restored in adherent-cell-depleted populations) by PI- or SF-stimulated adherent cells or by the filtered supernatants of such cultures; adjuvant-soluble factors are therefore involved in the phenomena of adherent, T- and B-cell cooperation required for the adjuvanticity of Brucella fractions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982864      PMCID: PMC347754          DOI: 10.1128/iai.38.2.413-418.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  One non-specific signal triggers b lymphocytes.

Authors:  G Möller
Journal:  Transplant Rev       Date:  1975

2.  Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure.

Authors:  V Braun; K Rehn
Journal:  Eur J Biochem       Date:  1969-10

3.  A role of macrophages in the stimulation of immune responses by adjuvants.

Authors:  E R Unanue; B A Askonas; A C Allison
Journal:  J Immunol       Date:  1969-07       Impact factor: 5.422

4.  Influence of MDP and of some analogous synthetic glycopeptides on the in vitro mouse spleen cell viability and immune response to sheep erythrocytes.

Authors:  C Leclerc; I Löwy; L Chedid
Journal:  Cell Immunol       Date:  1978-07       Impact factor: 4.868

5.  Adjuvant actions of polyclonal lymphocyte activators. I. Comparison and characterization of their actions in antibody response to deaggregated bovine serum albumin.

Authors:  I Nakashima; F Nagase; T Yokochi; M Ohta; N Kato
Journal:  Cell Immunol       Date:  1979-08       Impact factor: 4.868

6.  Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation.

Authors:  A C Allison; A J Davies
Journal:  Nature       Date:  1971-10-01       Impact factor: 49.962

7.  Relationships between adjuvant, immunosuppressive, and mitogenic activities of staphylococcal peptidoglycan.

Authors:  R Dziarski
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

8.  Some structural and biological properties of Brucella endotoxin.

Authors:  D Leong; R Diaz; K Milner; J Rudbach; J B Wilson
Journal:  Infect Immun       Date:  1970-02       Impact factor: 3.441

9.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens.

Authors:  J R McGhee; J J Farrar; S M Michalek; S E Mergenhagen; D L Rosenstreich
Journal:  J Exp Med       Date:  1979-04-01       Impact factor: 14.307

10.  Specificity of cytotoxic T cells from athymic mice.

Authors:  T Hünig; M J Bevan
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.